News

Data show the expression levels of miR-214, BNP, NT-proBNP, and sST2 were significantly higher compared to the control group.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

Italy and the Netherlands both achieved their target HBV control.

Infants between 6-12 months old had the highest prevalence of C difficile detection.

The first-in-class monoclonal antibody is the first therapeutic expansion for this patient population in over 10 years.

The app will deliver up-to-the-minute glucose data in patients using Freestyle Libre 2 glucose sensors.

It’s time to stop just recommending trigger avoidance strategies to patients. These are the proactive behaviors that will actually help improve migraine.

Severe mental disorders had the highest odds ratios for the risk of mortality.

Previous research has shown that COVID-19 can impact ocular health.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

The FDA approved selexipag tablets for PAH in 2015.

Studies are needed to determine the best treatment regimen for these patients.

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

The FDA noted the extent of the treatment effect of tenapanor is of unclear clinical significance, despite evidence of efficacy.

The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.

Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.

Higher microbiome α diversity had an association with less T2D and lower insulin resistance in individuals without diabetes.

OnabotulinumtoxinA treatment may now include 8 new muscles.

Data show no clinically meaningful difference between insulin glargine-yfgn and insulin glargine in matters of safety, purity and potency.

Data show a patient aged 65 years would have an extrapolated mean event-free survival of 6.2 years for placebo and 8.3 years for dapagliflozin, at a gain of 2.1 years.

For only reward learning, anhedonia was associated with model-derived learning parameters and neural learning signals.

In this series of HCPLive® State of the Science, 4 experts discuss knowledge and treatment in the cardiovascular risk management space.

Dr. Mazzocchi talks of the promising new cancer care therapies and how to properly inform and care for patients with cancer who may be overwhelmed.

OCTA can be used as a support technique to improve patient flow and reduce number of fluorescein angiography.

Data show dapagliflozin was projected to add 0.63 quality-adjusted life-years at an incremental lifetime cost of $42, 800.

Researchers in North Carolina recorded improvements in pediatric healthcare utilization partly attributed to a lack of exposure to allergens and other exacerbations.